Live from the NIH registry
Studies recruiting near Stockton right now
Top 25 of 100 recruiting studies, sorted by proximity — each links to its official registry page
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Memorial Medical Center — Modesto, California (28.9 mi)
· Sponsor: NRG Oncology
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Retinal Consultants Medical Group (Site 024) — Modesto, California (28.9 mi)
· Sponsor: EyeBiotech Ltd.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Memorial Medical Center — Modesto, California (28.9 mi)
· Sponsor: National Cancer Institute (NCI)
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.
Hypothyroidism
Phase 3
Interventional 466 participants sought
Paradigm Clinical Research Centers, LLC — Modesto, California (28.9 mi)
· Sponsor: Neuvosyn Laboratories, LLC
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Kaiser Permanente-Stockton — Stockton, California (1.7 mi)
· Sponsor: NRG Oncology
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Manshadi Heart Institute — Stockton, California (1.7 mi)
· Sponsor: Amgen
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Kaiser Permanente-Stockton — Stockton, California (1.7 mi)
· Sponsor: NRG Oncology
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Paradigm Clinical Research - Modesto — Modesto, California (28.9 mi)
· Sponsor: vTv Therapeutics
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Chronic Myelogenous Leukemia - Chronic Phase
N/A
Observational 1,000 participants sought
Stockton Hematology Oncology Medical Group Inc — Stockton, California (1.7 mi)
· Sponsor: Novartis Pharmaceuticals
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: SWOG Cancer Research Network
Mobile Health for Adherence in Breast Cancer Patients
Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma
N/A
Interventional 410 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: Canadian Cancer Trials Group
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Stockton — Stockton, California (1.7 mi)
· Sponsor: NRG Oncology
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Grade 2 Meningioma, Intracranial Meningioma
Phase 3
Interventional 163 participants sought
Memorial Medical Center — Modesto, California (28.9 mi)
· Sponsor: NRG Oncology
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
St. Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: Novo Nordisk A/S
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Memorial Medical Center — Modesto, California (28.9 mi)
· Sponsor: National Cancer Institute (NCI)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 2, Phase 3
Interventional 224 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi)
· Sponsor: National Cancer Institute (NCI)
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Prostate Cancer
Phase 3
Interventional 710 participants sought
Kaiser Permanente-Stockton — Stockton, California (1.7 mi)
· Sponsor: Canadian Cancer Trials Group
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Manshadi Heart Institute — Stockton, California (1.7 mi)
· Sponsor: Novartis Pharmaceuticals